The HIV virus can be transmitted through sharing needles, but a needle may very well be the answer for those people living with HIV, for whom treatment is a hard pill to swallow.
In the trial backed by Johnson & Johnson and GlaxoSmithKline, people living with the virus were given a shot containing two drugs every four or eight weeks. At both intervals, the shot worked just as well as people who were taking three pills per day to suppress their virus, Reuters reports.
In the trial backed by Johnson & Johnson and GlaxoSmithKline, people living with the virus were given a shot containing two drugs every four or eight weeks. At both intervals, the shot worked just as well as people who were taking three pills per day to suppress their virus, Reuters reports.
Paul Stoffels, head of pharmaceuticals at Johnson & Johnson, told Reuters that the findings were "transformational" in the fight against HIV. Stoffels said he believed the long-acting injection could help improve the lives of those living with HIV by 2020.
Having an alternative method of helping people stay HIV-undetectable is important for public health and for the personal health of those living with the virus. Currently, only 30% of the 1.2 million people living with HIV in the U.S. are undetectable.
Great job, Johnson & Johnson!
Source: http://mic.com/articles/128110/people-with-hiv-could-soon-stay-healthy-without-taking-any-pills#.7hhhxe8Ia
Having an alternative method of helping people stay HIV-undetectable is important for public health and for the personal health of those living with the virus. Currently, only 30% of the 1.2 million people living with HIV in the U.S. are undetectable.
Great job, Johnson & Johnson!
Source: http://mic.com/articles/128110/people-with-hiv-could-soon-stay-healthy-without-taking-any-pills#.7hhhxe8Ia
RSS Feed